Company profile: RoosterBio
1.1 - Company Overview
Company description
- Provider of synthetic biology and regenerative medicine solutions, including standardized hMSC 2D (flask) and 3D (bioreactor) bioprocess systems for scalable hMSC manufacturing, industrialized exosome/extracellular vesicle production from hMSCs across bioreactor platforms, and the Boost at the Roost protocol for high-efficiency cell cargo loading to enhance cell engineering for MSC and exosome therapies.
Products and services
- Standardized hMSC 3D (Bioreactor) Bioprocess Systems: A platform-agnostic system that scales hMSC manufacturing in 3D bioreactor cultures, ensuring efficient production across diverse bioreactor platforms
- Industrialized Exosome / Extracellular Vesicle (EV) Production: A multi-scale system enabling large-scale production of hMSC-derived exosomes and EVs, optimized for multiple scales and compatible with assorted bioreactor platforms
- Standardized hMSC 2D (Flask) BioProcess Systems: A scalable system for simplified scale-out of hMSCs in 2D flask cultures, facilitating rapid clinical translation
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to RoosterBio
Alderys
HQ: France
Website
- Description: Provider of innovative biological engineering approaches to produce chemical compounds of economic interest from renewable plant resources, including nutrients via rectified biosynthetic routes, targeting convenience chemicals, cosmetics, and animal nutrition markets, with environmentally respectful industrial technological solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alderys company profile →
BCF Life Sciences
HQ: France
Website
- Description: Provider of natural amino acids and derivatives for the pharmaceutical and health care industries. Specialises in extracting L-Cystine and L-Tyrosine of 100% traced origin and derivatives such as Carbocisteine. Offers L-Cystine, L-Tyrosine, Carbocisteine (expectorant API), Cysti-White, Kera-Diet keratin hydrolysate, and Leafamine (17 free amino acids) for food supplements, baby foods, and sustainable agriculture.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BCF Life Sciences company profile →
SAMDI Tech
HQ: United States
Website
- Description: Provider of contract assay services offering label-free biochemical assays for drug discovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SAMDI Tech company profile →
Protedyne
HQ: United States
Website
- Description: Provider of laboratory automation systems that integrate powerful laboratory robotic hardware and industrial automation design principles, bringing serious laboratory automation to LabCorp's diagnostic testing facilities nationwide and supporting existing pharmaceutical, biotech, and diagnostic testing customers as a wholly owned subsidiary of Laboratory Corporation of America.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Protedyne company profile →
Nortis Bio
HQ: United States
Website
- Description: Provider of organ-on-a-chip systems and tissue-engineering techniques that create human micro-tissue environments within small, disposable microfluidic chips, enabling living models of human organs to accelerate discovery and help scientists better understand the causes of human diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nortis Bio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for RoosterBio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to RoosterBio
2.2 - Growth funds investing in similar companies to RoosterBio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for RoosterBio
4.2 - Public trading comparable groups for RoosterBio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →